Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Eisai signs option agreement with Teikoku Seiyaku
The company also signed a licensing agreement on the same product for all countries except Japan with Teikoku Seiyaku’s US subsidiary, Teikoku Pharma USA. Under the terms of
The company also signed a licensing agreement on the same product for all countries except Japan with Teikoku Seiyaku’s US subsidiary, Teikoku Pharma USA. Under the terms of
Penwest Pharmaceuticals, a drug development company, has started dosing in a Phase Ib clinical trial of A0001, a compound the company is developing for the treatment of mitochondrial
According to ProGenTech, the system will incorporate Innovative Biosensor’s proprietary Cellular Analysis and Notification of Antigen Risks and Yields technology, a cell-based approach for detecting various pathogens, into
The Quigley Corporation, a manufacturer of homeopathic and health products, has signed a license with assignment of ownership agreement for its patented formulation QR-340 developed by its wholly
White brings more than 24 years of successful experience in the in vitro diagnostic marketplace to BG Medicine, including roles at innovative leading companies such as QIAGEN, Digene,
Luna Innovations announced its financial results for the fourth quarter and year ended December 31, 2008. As against the same quarter last year, fourth quarter 2008 revenues down
Avigen, a biopharmaceutical company, has announced that two preclinical reports with glial attenuator AV411 support the pharmacological effect of the drug on enhancing the pain-killing effect of opioids
Basilea Pharmaceutica has filed claims in arbitration against Johnson & Johnson and affiliated companies related to delays in approval of ceftobiprole. Basilea submitted a request for arbitration to
Nihon Kohden’s Patient Monitoring solutions utilize miniaturization technology and processing to provide clinicians with a feature rich value oriented product offering. Mike Dashefsky, vice president, patient monitoring, says,
In his role, Lusk will lead the national sales force, manage international distribution, and drive activities to market the Celerus Wave System, the first and only solution to